← back to search

Yongxin Mai

Guangzhou University of Chinese Medicine · CN
🔎 Find collaborators in Cancer Research · Molecular Biology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cell biology, Osteosarcoma, Cancer research, Chemistry, Pharmacology, and Wnt signaling pathway.
h-index
citations
230
works
17
NIH funding
primary concept
email

Recent publications

Silence of Linc01152 promotes chondrogenic differentiation and facilitates cartilage repair through directly increasing SOX9 expression
Osteoarthritis and Cartilage 2026cited by 0position: firstdoi
Silence of HOTAIR promotes osteogenic differentiation and accelerates distraction osteogenesis by mediating FTO ubiquitination
Journal of Orthopaedic Translation 2025cited by 4position: middledoi
HOTTIP suppresses ferroptosis via mediating DGCR8/miR‑214‑3p/GPX4 regulatory axis in osteosarcoma
Oncology Reports 2025cited by 2position: middledoi
Long noncoding RNA hottip maintained skeletal homeostasis via suppressing the enhancer of zeste homolog 2 (Ezh2)/histone methylation regulatory axis
Non-coding RNA Research 2025cited by 1position: middledoi
Polydatin sensitizes osteosarcoma cells to methotrexate through suppressing the H19/H3K27me3/H3K9me3 mediated folate metabolism regulatory axis
Bioorganic Chemistry 2025cited by 1position: middledoi
Polydatin Sensitizes Osteosarcoma Cells to Methotrexate Through Suppressing  the H19/H3k27me3/H3k9me3 Mediated Folate Metabolism Regulatory Axis
SSRN Electronic Journal 2025cited by 0position: middledoi
Corrigendum to “Polydatin sensitizes osteosarcoma cells to methotrexate through suppressing the H19/H3K27me3/H3K9me3 mediated folate metabolism regulatory axis” [Bioorg. Chem. 162 (2025) 108583]
Bioorganic Chemistry 2025cited by 0position: middledoi
[Aucubin alleviates knee osteoarthritis in mice by suppressing the NF‑κB signaling pathway].
PubMed 2025cited by 0position: firstdoi
Icariside II sensitizes osteosarcoma to doxorubicin through the lincROR/Wnt/β-catenin signaling regulatory axis
Naunyn-Schmiedeberg s Archives of Pharmacology 2025cited by 0position: middledoi
Aucubin Promotes Osteogenic Differentiation and Facilitates Bone Formation through the lncRNA‐H19 Driven Wnt/<i>β</i>‐Catenin Signaling Regulatory Axis
Stem Cells International 2024cited by 9position: firstdoi
Polydatin Sensitizes Methotrexatein Osteosarcoma Via the H19/H3k27me3/H3k9me3 Mediated Folate Metabolism Regulatory Axis
SSRN Electronic Journal 2024cited by 0position: middledoi
Baicalin induces ferroptosis in osteosarcomas through a novel Nrf2/xCT/GPX4 regulatory axis
Phytomedicine 2023cited by 189position: middledoi
Gallic acid mediates tumor-suppressive effects on osteosarcoma through the H19-Wnt/β-catenin regulatory axis
Journal of Orthopaedic Translation 2023cited by 16position: middledoi
Corrigendum to “Gallic acid mediates tumor-suppressive effects on osteosarcoma through the H19-Wnt/β-catenin regulatory axis” [J. Orthop. Translat. 39 (2023) 34–42].
Journal of Orthopaedic Translation 2023cited by 0position: middledoi
Long Noncoding RNA Hottip Maintained Skeletal Homeostasis &lt;i&gt;Via&lt;/i&gt; Suppressing the Enhancer of Zeste Homolog 2 (Ezh2)/Histone Methylation Regulatory Axis
SSRN Electronic Journal 2023cited by 0position: middledoi
Long noncoding RNA Hottip maintained skeletal homeostasis <i>via</i> suppressing the enhancer of zeste homolog 2 (Ezh2)/histone methylation regulatory axis
bioRxiv (Cold Spring Harbor Laboratory) 2023cited by 0position: middledoi
MLK3 silence suppressed osteogenic differentiation and delayed bone formation via influencing the bone metabolism and disturbing MAPK signaling
Journal of Orthopaedic Translation 2022cited by 8position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jinfang Zhang · Guangzhou University of Chinese Medicine12 papers (2022–2026)Chuan-Jian Shi · Guangzhou University of Chinese Medicine10 papers (2023–2025)Shou-chang Ding · Guangzhou University of Chinese Medicine9 papers (2023–2026)Shuting Zhou · Guangzhou University of Chinese Medicine8 papers (2023–2025)Feng-Xiang Pang · Guangzhou University of Chinese Medicine7 papers (2022–2025)Ruijia Wen · Guangzhou University of Chinese Medicine7 papers (2023–2025)Fengxiang Pang · Guangzhou University of Chinese Medicine5 papers (2023–2025)Zhipeng Li · University of California, Berkeley4 papers (2023–2025)Jinfang Zhang · Guangzhou University of Chinese Medicine4 papers (2024–2025)Nan Li · Guangzhou University of Chinese Medicine3 papers (2024–2025)Xianlin Wu · Guangzhou University of Chinese Medicine3 papers (2024–2025)Puping Liang · Sun Yat-sen University3 papers (2023–2025)Weicheng Liang · Sun Yat-sen University3 papers (2023–2025)Nan Li · Guangzhou University of Chinese Medicine3 papers (2024–2025)Junyan Wang · Guangzhou University of Chinese Medicine3 papers (2023–2023)Nannan Tian · Guangzhou University of Chinese Medicine2 papers (2023–2023)Yu-Yan Wang · Guangzhou University of Chinese Medicine2 papers (2024–2025)Zhipeng Li · Tianjin Medical University2 papers (2022–2025)Jiang Shao · Guangzhou University of Chinese Medicine2 papers (2023–2025)Fengwei Zhang · Guangzhou University of Chinese Medicine2 papers (2023–2023)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Cancer Research · Molecular Biology →